18 |
Klinisk Biokemi i Norden · 3 2019
References
1. Labunskyy VM, Hatfield DL, Gladyshev VN.
Selenoproteins: molecular pathways and phy-
siological roles. Physiol Rev 2014;94(3):739-77.
2. Alexander J. Selenium. In: Nordberg GF, Fowler,
B.A. and Nordberg, M., editor. Handbook on
the Toxicology of Metals 4ed. II. Amsterdam:
Academic Press/Elsevier; 2015. p. 1175-1208.
3. Observations on effect of sodium selenite in
prevention of Keshan disease. ChinMed J (Engl)
1979;92(7):471-6.
4. Fairweather-Tait SJ, Bao Y, Broadley MR, Col-
lings R, Ford D, Hesketh JE, et al. Selenium in
human health and disease. Antioxid Redox Sig-
nal 2011;14(7):1337-83.
5. EFSA. NDA Panel Scientific Opinion on Dietary
Reference Values for selenium. EFSA Journal
2014;12(10):3846.
6. Birgisdottir BE, Knutsen HK, Haugen M, Gjel-
stad IM, JenssenMT, Ellingsen DG, et al. Essen-
tial and toxic element concentrations in blood
and urine and their associations with diet: results
from a Norwegian population study including
high-consumers of seafood and game. Sci Total
Environ 2013;463-464:836-44.
7. Alehagen U, Alexander J, Aaseth J. Supple-
mentation with Selenium and Coenzyme Q10
Reduces Cardiovascular Mortality in Elderly
with Low Selenium Status. A Secondary Ana-
lysis of a Randomised Clinical Trial. PLoS One
2016;11(7):e0157541.
8. Rayman MP. Selenium in cancer prevention: a
review of the evidence and mechanism of action.
Proc Nutr Soc 2005;64(4):527-42.
9. Vanderlelie J, Perkins AV. Selenium and preec-
lampsia: A global perspective. Pregnancy Hyper-
tens 2011;1(3-4):213-24.
10. Burk RF, Hill KE. Regulation of Selenium
Metabolism and Transport. Annu Rev Nutr
2015;35:109-34.
11. Wu S, Mariotti M, Santesmasses D, Hill KE,
Baclaocos J, Aparicio-Prat E, et al. Human
selenoprotein P and S variant mRNAs with dif-
ferent numbers of SECIS elements and inferences
frommutant mice of the roles of multiple SECIS
elements. Open Biol 2016;6(11).
12. Lu J, Berndt C, Holmgren A. Metabolism of sele-
nium compounds catalyzed by the mammalian
selenoprotein thioredoxin reductase. Biochim
Biophys Acta 2009;1790(11):1513-9.
13. Takayama H, Misu H, Iwama H, Chikamoto
K, Saito Y, Murao K, et al. Metformin sup-
presses expression of the selenoprotein P gene
via an AMP-activated kinase (AMPK)/FoxO3a
pathway in H4IIEC3 hepatocytes. J Biol Chem
2014;289(1):335-45.
14. NNR. Nordic Nutrition Recommendations 2012.
Integrating nutrition and physical activity. 5 ed.
Copenhagen: Nordic Council of Ministers; 2014.
15. Salonen JT, Alfthan G, Huttunen JK, Pikkarai-
nen J, Puska P. Association between cardiovascu-
lar death and myocardial infarction and serum
selenium in a matched-pair longitudinal study.
Lancet 1982;2(8291):175-9.
16. Suadicani P, Hein HO, Gyntelberg F. Serum
selenium concentration and risk of ischaemic
heart disease in a prospective cohort study of
3000 males. Atherosclerosis 1992;96(1):33-42.
17. Lubos E, Sinning CR, Schnabel RB, Wild PS,
Zeller T, Rupprecht HJ, et al. Serum selenium
and prognosis in cardiovascular disease: results
from the AtheroGene study. Atherosclerosis
2010;209(1):271-7.
18. Kardinaal AF, Kok FJ, Kohlmeier L, Martin-
Moreno JM, Ringstad J, Gomez-Aracena J, et al.
Association between toenail selenium and risk of
acute myocardial infarction in European men.
The EURAMIC Study. European Antioxidant
Myocardial Infarction and Breast Cancer. Am J
Epidemiol 1997;145(4):373-9.
19. Hercberg S, Galan P, Preziosi P, Bertrais S, Men-
nen L, Malvy D, et al. The SU.VI.MAX Study:
a randomized, placebo-controlled trial of the
health effects of antioxidant vitamins and mine-
rals. Arch Intern Med 2004;164(21):2335-42.
20. Salvini S, Hennekens CH, Morris JS, Wil-
lett WC, Stampfer MJ. Plasma levels of the
antioxidant selenium and risk of myocardial
infarction among U.S. physicians. Am J Cardiol
1995;76(17):1218-21.
21. Rees K, Hartley L, Day C, Flowers N, Clarke A,
Stranges S. Selenium supplementation for the
primary prevention of cardiovascular disease.
Cochrane Database Syst Rev 2013;(1):CD009671.
